Sarda Proteins files 35th annual report for FY26 with BSE

scanx
Reviewed by
Shriram SScanX News Team
Key Highlights
  • Sarda Proteins filed its 35th Annual Report for FY26
  • Submission made to BSE on September 7, 2026
  • Filing complies with SEBI LODR Regulation 34
  • Managing Director Shirish Dhirajlal Savaliya signed off
powered bylight_fuzz_icon
50351784

*this image is generated using AI for illustrative purposes only.

Sarda Proteins Limited has submitted its 35th Annual Report for the financial year ended March 31, 2026, to the Bombay Stock Exchange. The filing was made on September 7, 2026.

The submission is pursuant to Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015. The company requested the exchange to take the report on record.

Shirish Dhirajlal Savaliya, Managing Director of Sarda Proteins, signed the communication. The document includes standard corporate identifiers and contact details for the company's management.

What were the key financial highlights and revenue growth figures reported in Sarda Proteins' 35th Annual Report for FY2026?

How does the company plan to leverage its recent performance to expand its market share in the competitive meat processing sector?

Are there any announced capital expenditure plans or new facility expansions detailed in the report for the upcoming fiscal year?

like15
dislike

Sarda Proteins seeks approval for ₹1,000 crore borrowing at AGM

scanx
Reviewed by
Naman SScanX News Team
Key Highlights
  • Sarda Proteins schedules 35th AGM for September 30, 2026, via VC/OAVM
  • Seeks approval for borrowing powers up to ₹1,000 crore under Section 180(1)(c)
  • Proposes investment and loan limits of ₹1,000 crore under Section 186
  • Reappointment of Director Shivam Zaladi and audit firm A H Mandaliya & Associates on agenda
powered bylight_fuzz_icon
49729711

*this image is generated using AI for illustrative purposes only.

Sarda Proteins Limited has scheduled its 35th Annual General Meeting (AGM) for September 30, 2026. The meeting will feature key corporate governance decisions, including the reappointment of a retiring director and the formal appointment of statutory auditors.

The Board of Directors approved the convening of the meeting during a session held on September 7, 2026. The company notified the BSE Limited under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The AGM will be conducted through Video Conferencing (VC) or Other Audio Visual Means (OAVM), in accordance with the Companies Act, 2013 and relevant circulars from the Ministry of Corporate Affairs and SEBI.

Key Agenda Items

The notice outlines both ordinary and special business for shareholder approval:

  • Reappointment of Director: Mr. Shivam Gunvantray Zaladi (DIN: 11251860), who retires by rotation, offers himself for reappointment as a Non-Executive Director. He holds a B.Com degree and specializes in finance and strategic planning.
  • Statutory Auditors: Members are asked to appoint M/s. A H Mandaliya & Associates, Chartered Accountants (FRN: 146705W), as Statutory Auditors for a term of five consecutive years. They were initially appointed by the Board on February 14, 2026, to fill a casual vacancy for FY26.

Special Resolutions: Borrowing and Investment Powers

The most significant items on the agenda are two Special Resolutions seeking enhanced financial flexibility for the company:

  1. Borrowing Powers: Approval is sought under Section 180(1)(c) of the Companies Act, 2013, to authorize the Board to borrow funds up to an aggregate outstanding amount of ₹1,000 crore. This limit applies apart from temporary loans obtained from bankers in the ordinary course of business. The funds may be used for expansion, working capital, capital expenditure, and other corporate purposes.
  2. Loans, Guarantees, and Investments: Pursuant to Section 186 of the Companies Act, 2013, shareholders are asked to approve the Board’s power to give loans, provide guarantees/securities, and make investments up to an aggregate limit of ₹1,000 crore. This enables the company to support subsidiaries, associates, and joint ventures.

AGM Logistics and E-Voting

The Board fixed the following dates and times for the upcoming corporate action:

  • AGM Date: Wednesday, September 30, 2026 at 11:00 am.
  • Mode: Video Conferencing / Other Audio Visual Means.
  • Register Closure: Thursday, September 24, 2026 to Wednesday, September 30, 2026 (both days inclusive).

Members entitled to vote must be on the register as of the cut-off date. The Board approved the following timeline for remote e-voting:

Parameter Details
Cut-off Date Wednesday, September 23, 2026
Remote E-voting Start Saturday, September 26, 2026 at 9:00 am
Remote E-voting End Tuesday, September 29, 2026 at 5:00 pm
Event No. 260661

The company has engaged MUFG Intime India Private Limited (formerly Link Intime India Private Limited) to provide InstaVote and InstaMeet facilities. Mr. Himansu Togadiya, Practicing Company Secretary (FCS No. 11822, CP No. 18233), has been appointed as the Scrutinizer for the e-voting process.

Shirish Dhirajlal Savaliya, Managing Director, signed the intimation letter addressed to the General Manager of BSE Limited in Mumbai.

How will Sarda Proteins plan to utilize the newly authorized ₹1,000 crore borrowing limit to accelerate its expansion or capital expenditure projects?

What specific strategic investments or subsidiary support initiatives are anticipated under the new ₹1,000 crore limit for loans, guarantees, and investments?

How might the reappointment of Mr. Shivam Gunvantray Zaladi influence the company's future financial strategy and corporate governance direction?

like20
dislike

More News on Sarda Proteins Limited